Growth hormone deficiency in patients in long-term remission of adrenal Cushing's syndrome

Recruiting

• Conditions: groeihormoondeficiëntie; 10021112

• Registration Number: NL-OMON36195
• Lead Sponsor: niversitair Medisch Centrum Sint Radboud

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 16

Inclusion Criteria

- Remission of Cushing*s syndrome due to adrenal adenoma for at least four years.
- Proven remission by a 1 mg dexamethasone suppression test within the last year.

Exclusion Criteria

- Patients cured of an adrenal carcinoma.
- BMI >30 kg/m2.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>GH secretory response to an ITT or an Arginine/GHRH test. The endpoint is GH<br /><br>deficiency as defined in the consensus of the endocrine society in 2006. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable.</p><br>